How to buy Doximity stock (Doximity)

Doximity is a health information services business based in the US. Doximity shares (DOCS) are listed on the NYSE and all prices are listed in US Dollars. Its last market close was $57.83 – an increase of 10.91% over the previous week. Doximity employs 827 staff and has a trailing 12-month revenue of around $516.8 million.

Our top picks for where to buy Doximity stock

Buy Doximity stock from these online trading platforms

Compare special offers, low fees and a wide range of investment options among top trading platforms.

Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.

Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.

Doximity stock price (NYSE: DOCS)

Use our graph to track the performance of DOCS stocks over time.

Doximity shares at a glance

• Key figures

Information last updated 2024-12-19.

Latest market close	$57.83
52-week range	$22.96 - $61.75
50-day moving average more info button	$48.24
200-day moving average more info button	$34.62
Wall St. target price	$55.25
PE ratio more info button	59.9885
Dividend yield more info button	N/A
Earnings per share (TTM) more info button	$0.87

Is it a good time to buy Doximity stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Doximity price performance over time

Historical closes compared with the close of $55.18 from 2024-12-19

1 week (2024-12-13)	5.83%
1 month (2024-11-21)	14.96%
3 months (2024-09-20)	34.98%
6 months (2024-06-21)	100.51%

1 year (2023-12-21)	96.72%
2 years (2022-12-21)	54.83%
3 years (2021-12-21)	13.17%
5 years (2019-12-17)	N/A

Is Doximity stock undervalued or overvalued?

Valuing Doximity stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Doximity's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

Doximity's P/E ratio

Doximity's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 60x. In other words, Doximity shares trade at around 60x recent earnings.

That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.

However, Doximity's P/E ratio is best considered in relation to those of others within the health information services industry or those of similar companies.

• Nextgen Healthcare (NXGN.US): 0.00
• Cerner (CERN.US): 48.06
• Veradigm (MDRX.US): 11.08

Doximity's PEG ratio

Doximity's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 2.4191. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.

The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Doximity's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.

However, it's sensible to consider Doximity's PEG ratio in relation to those of similar companies.

• Nextgen Healthcare (NXGN.US): 2.56
• Cerner (CERN.US): 5.66
• Veradigm (MDRX.US): 2.42

Doximity's EBITDA

Doximity's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $207.9 million.

The EBITDA is a measure of a Doximity's overall financial performance and is widely used to measure a its profitability.

To put Doximity's EBITDA into context you can compare it against that of similar companies.

• Nextgen Healthcare (NXGN.US): USD$54.5 million
• Cerner (CERN.US): USD$1.6 billion
• Veradigm (MDRX.US): USD$115.4 million

Doximity financials

Revenue TTM	$516.8 million
Operating margin TTM	40.68%
Gross profit TTM	$365.6 million
Return on assets TTM	11.83%
Return on equity TTM	19%
Profit margin	33.69%
Book value	$5.15
Market Capitalization more info button	$9.7 billion

TTM: trailing 12 months

Doximity share dividends

We're not expecting Doximity to pay a dividend over the next 12 months.

You may also wish to consider:

• Cerner (CERN.US) (1.14% forward annual dividend yield)

Doximity share price volatility

Over the last 12 months, Doximity's shares have ranged in value from as little as $22.96 up to $61.75. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while Doximity's is 1.296. This would suggest that Doximity's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).

To put Doximity's beta into context you can compare it against those of similar companies.

• Nextgen Healthcare (NXGN.US): 0.77
• Cerner (CERN.US): 0.7613
• Veradigm (MDRX.US): 0.604

Doximity overview

Doximity, Inc. operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with digital tools built for medicine, that enables its members to collaborate with colleagues, stay up to date with the latest medical news and research, manage their careers and on-call schedules, streamline documentation and administrative paperwork, and conduct virtual patient visits. It primarily serves physicians, nurse practitioners, physician assistants, medical students, pharmaceutical manufacturers, and healthcare systems. The company was formerly known as 3MD Communications, Inc. and changed its name to Doximity, Inc. in June 2010.

Frequently asked questions

null
What percentage of Doximity is owned by insiders or institutions?
Currently 2.717% of Doximity shares are held by insiders and 93.051% by institutions. How many people work for Doximity?
Latest data suggests 827 work at Doximity. When does the fiscal year end for Doximity?
Doximity's fiscal year ends in March. Where is Doximity based?
Doximity's address is: 500 3rd Street, San Francisco, CA, United States, 94107 What is Doximity's ISIN number?
Doximity's international securities identification number is: US26622P1075